2022 / 03

Next Paper
DOI: 10.24075/brsmu.2022.026

CLINICAL CASE

The role of genetic factors in familial case of acne

Demina OM1, Rumyantsev AG1,2, Potekaev NN1
About authors

1 Pirogov Russian National Research Medical University, Moscow, Russia

2 Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia

Correspondence should be addressed: Olga М. Demina
Ostrovityanova, 1, Moscow, 117997, Russia; ur.liam@mo.animed

About paper

Author contribution: Demina OM, Rumyantsev AG, Potekaev NN — study concept and design, manuscript writing; Demina OM — sequencing data management, computational research; Rumyantsev AG, Potekaev NN — manuscript editing.

Compliance with ethical standards: the study was approved by Ethical Review Board at the Pirogov Russian National Research Medical University (protocol number 138 of 13 October 2014). The participants provided written informed consent for the study including data processing and use for scientific purposes.

Received: 2022-04-03 Accepted: 2022-05-04 Published online: 2022-05-20
|
  1. Heng AS, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020; 10 (1): 5754. PubMed PMID: 32238884 DOI: 10.1038/s41598-020-62715-3.
  2. Cong TX, Hao D, Wen X, Li XH, He G, Jiang X. From pathogenesis of acne vulgaris to anti-acne agents. Arch Dermatol Res. 2019; 311 (5): 337–49. PubMed PMID: 30859308 DOI: 10.1007/ s00403-019-01908-x.
  3. Lichtenberger R, Simpson MA, Smith C, Barker J, Navani AA. Genetic architecture of acne vulgaris. J Eur Acad Dermatol Venereol. 2017; 31: 1978–90. PubMed PMID: 28593717 DOI: 10.1111/jdv.14385.
  4. Xu SX, Wang HL, Fan X, Sun LD, Yahg S, Wang PG, et al. The familial risk of acne vulgaris in Chinese Hans — a case–control study. J Eur Acad Dermatol Venereol. 2007; 21: 602–5. PubMed PMID:17447973 DOI: 10.1111/j.1468-3083.2006.02022.x.
  5. Abo El-Fetoh NM, Alenezi NG, Alshamari NG, Alenezi OG. Epidemiology of acne vulgaris in adolescent male students in Arar, Kingdom of Saudi Arabia. J Egypt Public Health Assoc. 2016; 91 (3): 144–9. PubMed PMID: 27749646 DOI: 10.1097/01. EPX.0000492401.39250.62.
  6. Kuhns DB, Hsu AP, Sun D, Lau K, Fink D, Griffith P, et al. NCF1 (p47phox)-deficient chronic granulomatous disease: comprehensive genetic and flow cytometric analysis. Blood Adv. 2019; 3 (2): 136–47. PubMed PMID: 30651282 DOI: 10.1182/ bloodadvances.2018023184.
  7. Linge P, Arve S, Olsson LM, Leonard D, Sjöwall C, Frodlund M, et al. NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus. Ann Rheum Dis. 2020; 79 (2): 254–61. PubMed PMID: 31704719 DOI: 10.1136/annrheumdis-2019-215820.
  8. Li L, Guo X, Shi X, Li C, Wu W, Yan C, et al. Ionic CD3-Lck interaction regulates the initiation of T-cell receptor signaling. Proc Natl Acad Sci USA. 2017; 114 (29): E5891–9. PubMed PMID: 28659468 DOI: 10.1073/pnas.1701990114.
  9. Firtina S, Ng YY, Ng OH, Nepesov S, Yesilbas O, Kilercik M, et al. A novel pathogenic frameshift variant of CD3E gene in two T-B+ NK+ SCID patients from Turkey.Immunogenetics. 2017; 69 (10): 653–9. PubMed PMID: 28597365 DOI: 10.1007/s00251-0171005-7.
  10. Bhardway R, Hediger M, Demaurex N. Redox modulation of Stim-Orai signaling. Cell Calcium. 2016; 60: 142–52. PubMed PMID:27041216 DOI: 10.1016/j.ceca.2016.03.006.
  11. Thompson JL, Mignen O, Shuttleworth TJ. The Orai1 severe combined immune deficiency mutation and calcium releaseactivated Ca2+ channel function in the heterozygous condition. J Biol Chem. 2009; 284 (11): 6620–6. PubMed PMID: 19075015 DOI: 10.1074/jbc.M808346200.
  12. Yan S, Chen W, Zhang Y, Li J, Chen X. Calcium releaseactivated calcium modulator 1 as a therapeutic target in allergic skin diseases. Life Sci. 2019; 228: 152–7. PubMed PMID: 31055088 DOI: 10.1016/j.lfs.2019.05.001.
  13. Lian J, Cuk M, Kahlfuss S, Kozhaya L, Vaeth M, Rieux-Laucat F, et al. ORAI1 mutations abolishing store-operated Ca2+ entry cause anhidrotic ectodermal dysplasia with immunodeficiency. J Allergy Clin Immunol. 2018; 142 (4): 1297–310. PubMed PMID: 29155098 DOI: 10.1016/j.jaci.2017.10.031.
  14. Silva P, Justicia A, Regueiro A, Fariña S, Couselo JM, Loidi L. Autosomal recessive agammaglobulinemia due to defect in μ heavy chain caused by a novel mutation in the IGHM gene. Genes Immun. 2017; 18 (3): 197–9. DOI: 28769069 10.1038/ gene.2017.14.
  15. Zapała B, Płatek T, Wybrańska I. A novel TAZ gene mutation and mosaicism in a Polish family with Barth syndrome. Ann Hum Genet. 2015; 79 (3): 218–24. PubMed PMID: 25776009 DOI: 10.1111/ahg.12108.